Filing metadata

Accession number
0001140361-22-002078
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Jan 19, 2022
Reporting period
Jan 14, 2022
Description
Insider transaction

Explore SEC Filings Hub